{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:34:24Z","timestamp":1791228864252,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2024NSCQ-MSX0317"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0317"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Funding for Postdoctoral Research Projects in Chongqing","award":["2023CQBSHTB3085"],"award-info":[{"award-number":["2023CQBSHTB3085"]}]},{"name":"Key Project of Chongqing Technology Innovation and Application Development Special Project","award":["CSTB2023TIAD-KPX0053"],"award-info":[{"award-number":["CSTB2023TIAD-KPX0053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-026-01122-4","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:23:43Z","timestamp":1772256223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanoparticles co-loaded with bacillus Calmette-Gu\u00e9rin pure protein derivative and doxorubicin for bladder tumor therapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Jindong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"1","key":"1122_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1122_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41585-020-00394-5","volume":"18","author":"E Heath","year":"2021","unstructured":"Heath E, Rosenberg JE. The biology and rationale of targeting nectin-4 in urothelial carcinoma. Nat Rev Urol. 2021;18(2):93\u2013103.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"1122_CR3","first-page":"44","volume":"9","author":"YH Jin","year":"2022","unstructured":"Jin YH, Zeng XT, Liu TZ, Bai ZM, Dou ZL, Ding DG, et al. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res. 2022;9(1):44.","journal-title":"Mil Med Res"},{"issue":"19","key":"1122_CR4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder Cancer: A Review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"2","key":"1122_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/bju.14915","volume":"125","author":"J Taylor","year":"2020","unstructured":"Taylor J, Becher E, Steinberg GD. Update on the guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2020;125(2):197\u2013205.","journal-title":"BJU Int"},{"key":"1122_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jconrel.2022.09.055","volume":"351","author":"B Zheng","year":"2022","unstructured":"Zheng B, Liu Z, Wang H, Sun L, Lai WF, Zhang H, et al. R11 modified tumor cell membrane nanovesicle-camouflaged nanoparticles with enhanced targeting and mucus-penetrating efficiency for intravesical chemotherapy for bladder cancer. J Control Release. 2022;351:834\u201346.","journal-title":"J Control Release"},{"issue":"41","key":"1122_CR7","doi-asserted-by":"publisher","first-page":"17218","DOI":"10.1039\/D1NR05512G","volume":"13","author":"M Jiang","year":"2021","unstructured":"Jiang M, Zeng J, Zhao L, Zhang M, Ma J, Guan X, et al. Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy. Nanoscale. 2021;13(41):17218\u201335.","journal-title":"Nanoscale"},{"issue":"12","key":"1122_CR8","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG. Targeting immunogenic cell death in cancer. Mol Oncol. 2020;14(12):2994\u20133006.","journal-title":"Mol Oncol"},{"issue":"7","key":"1122_CR9","doi-asserted-by":"publisher","first-page":"e2112696119","DOI":"10.1073\/pnas.2112696119","volume":"119","author":"N Kong","year":"2022","unstructured":"Kong N, Zhang R, Wu G, Sui X, Wang J, Kim NY, et al. Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. Proc Natl Acad Sci U S A. 2022;119(7):e2112696119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1122_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S1470-2045(11)70190-5","volume":"12","author":"SM Di Stasi","year":"2011","unstructured":"Di Stasi SM, Valenti M, Verri C, Liberati E, Giurioli A, Leprini G, et al. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. Lancet Oncol. 2011;12(9):871\u20139.","journal-title":"Lancet Oncol"},{"issue":"9","key":"1122_CR11","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/vaccines11091440","volume":"11","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ma R, Zhang M, Cao Y, Zhang Z, Yang W. Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy. Vaccines (Basel). 2023;11(9):1440.","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"1122_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23(4):487\u2013500.","journal-title":"Nat Immunol"},{"key":"1122_CR13","doi-asserted-by":"publisher","first-page":"114444","DOI":"10.1016\/j.addr.2022.114444","volume":"188","author":"S Li","year":"2022","unstructured":"Li S, Yue H, Wang S, Li X, Wang X, Guo P, et al. Advances of bacteria-based delivery systems for modulating tumor microenvironment. Adv Drug Deliv Rev. 2022;188:114444.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"1122_CR14","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-14-0728","volume":"74","author":"C B\u00fcll","year":"2014","unstructured":"B\u00fcll C, Stoel MA, den Brok MH, Adema GJ. Sialic acids sweeten a tumor\u2019s life. Cancer Res. 2014;74(12):3199\u2013204.","journal-title":"Cancer Res"},{"issue":"1","key":"1122_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","volume":"124","author":"C Dobie","year":"2021","unstructured":"Dobie C, Skropeta D. Insights into the role of sialylation in cancer progression and metastasis. Br J Cancer. 2021;124(1):76\u201390.","journal-title":"Br J Cancer"},{"issue":"41","key":"1122_CR16","doi-asserted-by":"publisher","first-page":"15501","DOI":"10.1021\/ja406406h","volume":"135","author":"S Deshayes","year":"2013","unstructured":"Deshayes S, Cabral H, Ishii T, Miura Y, Kobayashi S, Yamashita T, et al. Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors. J Am Chem Soc. 2013;135(41):15501\u20137.","journal-title":"J Am Chem Soc"},{"issue":"24","key":"1122_CR17","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.7150\/thno.33470","volume":"9","author":"X Qian","year":"2019","unstructured":"Qian X, Ge L, Yuan K, Li C, Zhen X, Cai W, et al. Targeting and microenvironment-improving of phenylboronic acid-decorated soy protein nanoparticles with different sizes to tumor. Theranostics. 2019;9(24):7417\u201330.","journal-title":"Theranostics"},{"issue":"1","key":"1122_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.annonc.2023.09.3116","volume":"35","author":"JWF Catto","year":"2024","unstructured":"Catto JWF, Tran B, Roupr\u00eat M, Gschwend JE, Loriot Y, Nishiyama H, et al. Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer. Ann Oncol. 2024;35(1):98\u2013106.","journal-title":"Ann Oncol"},{"issue":"6","key":"1122_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.urolonc.2023.04.003","volume":"41","author":"T Kawada","year":"2023","unstructured":"Kawada T, Yanagisawa T, Bekku K, Laukhtina E, von Deimling M, Chlosta M, et al. The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis. Urol Oncol. 2023;41(6):261\u201373.","journal-title":"Urol Oncol"},{"key":"1122_CR20","doi-asserted-by":"crossref","unstructured":"Liu M, Zhang J, Chen S, Zheng J, Xiao L, Liu X et al. NIR-triggered metal-polyphenol nanoparticles enhance HPV-driven cancer immunotherapy via immunogenic cell death and STING sequential activation. Adv Healthc Mater. 2025:e02884.","DOI":"10.1002\/adhm.202502884"},{"key":"1122_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jconrel.2021.02.032","volume":"332","author":"J Zheng","year":"2021","unstructured":"Zheng J, Sun J, Chen J, Zhu S, Chen S, Liu Y, et al. Oxygen and oxaliplatin-loaded nanoparticles combined with photo-sonodynamic inducing enhanced immunogenic cell death in syngeneic mouse models of ovarian cancer. J Control Release. 2021;332:448\u201359.","journal-title":"J Control Release"},{"issue":"21","key":"1122_CR22","doi-asserted-by":"publisher","first-page":"e158799","DOI":"10.1172\/jci.insight.158799","volume":"7","author":"S Gc","year":"2022","unstructured":"Gc S, Tuy K, Rickenbacker L, Jones R, Chakraborty A, Miller CR, et al. \u03b12,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth. JCI Insight. 2022;7(21):e158799.","journal-title":"JCI Insight"},{"issue":"6","key":"1122_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/cancers10060207","volume":"10","author":"E Rodrigues","year":"2018","unstructured":"Rodrigues E, Macauley MS. Hypersialylation in cancer: modulation of inflammation and therapeutic opportunities. Cancers. 2018;10(6):207.","journal-title":"Cancers"},{"issue":"1","key":"1122_CR24","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, Aaby P, Behr MA, Donald PR, Kaufmann SHE, Netea MG, et al. 100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin. Lancet Infect Dis. 2022;22(1):e2\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"1122_CR25","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.3390\/cancers14133073","volume":"14","author":"S Jiang","year":"2022","unstructured":"Jiang S, Redelman-Sidi G. BCG in Bladder Cancer Immunotherapy. Cancers (Basel). 2022;14(13):3073.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1122_CR26","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","volume":"12","author":"JS Woodworth","year":"2021","unstructured":"Woodworth JS, Clemmensen HS, Battey H, Dijkman K, Lindenstr\u00f8m T, Laureano RS, et al. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Gu\u00e9rin. Nat Commun. 2021;12(1):6658.","journal-title":"Nat Commun"},{"key":"1122_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2019.10.052","volume":"316","author":"Y Huang","year":"2019","unstructured":"Huang Y, Shi Y, Wang Q, Qi T, Fu X, Gu Z, et al. Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma. J Control Release. 2019;316:208\u201322.","journal-title":"J Control Release"},{"issue":"10","key":"1122_CR28","first-page":"3473","volume":"6","author":"X Li","year":"2021","unstructured":"Li X, Li H, Zhang C, Pich A, Xing L, Shi X. Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy. Bioact Mater. 2021;6(10):3473\u201384.","journal-title":"Bioact Mater"},{"issue":"8","key":"1122_CR29","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1021\/acs.molpharmaceut.6b00313","volume":"13","author":"K Sevim","year":"2016","unstructured":"Sevim K, Pan J. A Mechanistic Model for Acidic Drug Release Using Microspheres Made of PLGA 50:50. Mol Pharm. 2016;13(8):2729\u201335.","journal-title":"Mol Pharm"},{"key":"1122_CR30","doi-asserted-by":"publisher","first-page":"1460565","DOI":"10.3389\/fmolb.2025.1460565","volume":"12","author":"A Tarczykowska","year":"2025","unstructured":"Tarczykowska A, Malmberg P, Scheers N. Uptake of iron from ferrous fumarate can be mediated by clathrin-dependent endocytosis in Hutu-80 cells. Front Mol Biosci. 2025;12:1460565.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"1122_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1586\/erm.09.15","volume":"9","author":"JM L\u00fc","year":"2009","unstructured":"L\u00fc JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009;9(4):325\u201341.","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"1122_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1586\/erp.12.65","volume":"12","author":"R Becker","year":"2012","unstructured":"Becker R, Dembek C, White LA, Garrison LP. The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature. Expert Rev Pharmacoecon Outcomes Res. 2012;12(6):775\u201393.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1122_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-3155-9-55","volume":"9","author":"A Mahapatro","year":"2011","unstructured":"Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol. 2011;9:55.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1122_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","volume":"8","author":"N Bertrand","year":"2017","unstructured":"Bertrand N, Grenier P, Mahmoudi M, Lima EM, Appel EA, Dormont F, et al. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nat Commun. 2017;8(1):777.","journal-title":"Nat Commun"},{"issue":"3","key":"1122_CR35","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00210-023-02699-9","volume":"397","author":"S Kaur","year":"2024","unstructured":"Kaur S, Saini AK, Tuli HS, Garg N, Joshi H, Varol M, et al. Polymer-mediated nanoformulations: a promising strategy for cancer immunotherapy. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(3):1311\u201326.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"1122_CR36","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3390\/polym13101645","volume":"13","author":"D Valor","year":"2021","unstructured":"Valor D, Montes A, Monteiro M, Garc\u00eda-Casas I, Pereyra C, Mart\u00ednez de la Ossa E. Determining the Optimal Conditions for the Production by Supercritical CO2 of Biodegradable PLGA Foams for the Controlled Release of Rutin as a Medical Treatment. Polym (Basel). 2021;13(10):1645.","journal-title":"Polym (Basel)"},{"key":"1122_CR37","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/0973-1482.139267","volume":"10","author":"S Rivankar","year":"2014","unstructured":"Rivankar S. An overview of doxorubicin formulations in cancer therapy. J Cancer Res Ther. 2014;10:853\u20138.","journal-title":"J Cancer Res Ther"},{"issue":"6","key":"1122_CR38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/ph16060802","volume":"16","author":"J Lee","year":"2023","unstructured":"Lee J, Choi MK, Song IS. Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. Pharmaceuticals (Basel). 2023;16(6):802.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"15","key":"1122_CR39","doi-asserted-by":"publisher","first-page":"e2309591","DOI":"10.1002\/adma.202309591","volume":"36","author":"H Wang","year":"2024","unstructured":"Wang H, Chen Y, Wei R, Zhang J, Zhu J, Wang W, et al. Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel-Mediated Reprogramming of Cancer-Associated Fibroblasts in Osteosarcoma. Adv Mater. 2024;36(15):e2309591.","journal-title":"Adv Mater"},{"issue":"1","key":"1122_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/cdd.2013.48","volume":"21","author":"AD Garg","year":"2014","unstructured":"Garg AD, Martin S, Golab J, Agostinis P. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ. 2014;21(1):26\u201338.","journal-title":"Cell Death Differ"},{"issue":"10","key":"1122_CR41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.31083\/j.fbl2810260","volume":"28","author":"J Wen","year":"2023","unstructured":"Wen J, Zhang X. HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress. Front Biosci (Landmark Ed). 2023;28(10):260.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"12","key":"1122_CR42","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375.","journal-title":"Nat Rev Cancer"},{"key":"1122_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31:51\u201372.","journal-title":"Annu Rev Immunol"},{"issue":"19","key":"1122_CR44","doi-asserted-by":"publisher","first-page":"e2310735","DOI":"10.1002\/adma.202310735","volume":"36","author":"K Liu","year":"2024","unstructured":"Liu K, Wang L, Peng J, Lyu Y, Li Y, Duan D, et al. Drug-Loaded Bacillus Calmette-Gu\u00e9rin Bacteria for Immuno-Chemo Combo Therapy in Bladder Cancer. Adv Mater. 2024;36(19):e2310735.","journal-title":"Adv Mater"},{"issue":"11","key":"1122_CR45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/glycob\/cwad083","volume":"33","author":"B Tumoglu","year":"2023","unstructured":"Tumoglu B, Keelaghan A, Avci FY. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease. Glycobiology. 2023;33(11):879\u201387.","journal-title":"Glycobiology"},{"issue":"7","key":"1122_CR46","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00262-021-03072-6","volume":"71","author":"TM Abdullah","year":"2022","unstructured":"Abdullah TM, Whatmore J, Bremer E, Slibinskas R, Michalak M, Eggleton P. Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells. Cancer Immunol Immunother. 2022;71(7):1655\u201369.","journal-title":"Cancer Immunol Immunother"},{"key":"1122_CR47","doi-asserted-by":"publisher","first-page":"105060","DOI":"10.1016\/j.cellimm.2025.105060","volume":"419","author":"J Cuenca-Escalona","year":"2025","unstructured":"Cuenca-Escalona J, Kramer R, Marjalizo-Jimenez C, Dom\u00ednguez-Andr\u00e9s J, Netea MG, Fl\u00f3rez-Grau G, et al. BCG and beta-glucan primed monocytes yield dendritic cells that hamper the induction of pro-inflammatory T cell immunity. Cell Immunol. 2025;419:105060.","journal-title":"Cell Immunol"},{"issue":"10","key":"1122_CR48","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41417-025-00948-y","volume":"32","author":"C Guerrero","year":"2025","unstructured":"Guerrero C, Casal M, Alierta C, Moreo E, Araujo-Voces M, Uranga S, et al. NK cells mediate preventive efficacy of intravenous BCG against lung metastasis in mice. Cancer Gene Ther. 2025;32(10):1090\u20137.","journal-title":"Cancer Gene Ther"},{"key":"1122_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cyto.2017.05.024","volume":"97","author":"A Showalter","year":"2017","unstructured":"Showalter A, Limaye A, Oyer JL, Igarashi R, Kittipatarin C, Copik AJ, et al. Cytokines in immunogenic cell death: Applications for cancer immunotherapy. Cytokine. 2017;97:123\u201332.","journal-title":"Cytokine"},{"issue":"5","key":"1122_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bjc.2016.172","volume":"115","author":"H Bronger","year":"2016","unstructured":"Bronger H, Singer J, Windm\u00fcller C, Reuning U, Zech D, Delbridge C, et al. CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. Br J Cancer. 2016;115(5):553\u201363.","journal-title":"Br J Cancer"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01122-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01122-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01122-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:19:46Z","timestamp":1775571586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-026-01122-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01122-4","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Medical Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval Number: 2022-043), and written informed consent was obtained from all participants. All procedures adhered to the ethical standards set by the Institutional Ethics Committee on human experimentation and were in compliance with the Helsinki Declaration. Additionally, the Animal Ethics Committee of Chongqing Medical University (Approval number: 2022-K52) granted approval for the animal study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work the author(s) used WeTab AI Pro in order to improve language and readability. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}